Our mission is to fund research with the highest probability of preventing, slowing or reversing Alzheimer's Disease through venture based philanthropy. All organizational expenses are paid for by the Founders and Board, allowing all other contributions to be applied directly to Alzheimer's Disease research.
Each of GlobalGiving’s nonprofit partners is required to send quarterly donor reports detailing the impact of their work. Here are some of their recent updates:
By Laurel Lyle | VP-Development Operations and Board Relations
The Framingham Heart Study (FHS) has tracked more than 14,000 men and women and gathered extensive information about these participants, including their demographics, cardiovascular risk factors,... Read the full report ›By Laurel Lyle | Project Leader
Some individuals seem to be resilient to AD. Although these individuals develop the classic hallmarks of the disease—bundles of amyloid plaque and neurofibrillary tau tangles—they do not... Read the full report ›By Laurel Lyle | VP-Development Operations
As with our hearts, there is now evidence that exercise benefits our brains. While we exercise, the hormone irisin is secreted by our muscles. This hormone modulates the metabolic processes and... Read the full report ›